.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Nifedipine - Generic Drug Details

« Back to Dashboard
Nifedipine is the generic ingredient in six branded drugs marketed by Matrix Labs Ltd, Mylan, Chase Labs Nj, Osmotica Pharm, Martec Usa Llc, Twi Pharms Inc, Osmotica Pharm Us, Watson Labs, Heritage Pharma, Validus Pharms, Teva, Actavis Elizabeth, Valeant Pharms North, Bayer Pharms, Intergel Pharm, Pfizer, Novast Labs Ltd, Alvogen, and Par Pharm, and is included in twenty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-nine drug master file entries for nifedipine. Fifty-one suppliers are listed for this compound.

Summary for Generic Name: nifedipine

Tradenames:6
Patents:0
Applicants:19
NDAs:28
Drug Master File Entries: see list39
Suppliers / Packaging: see list51
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan
NIFEDIPINE
nifedipine
TABLET, EXTENDED RELEASE;ORAL090649-003Jun 21, 2010RXNo► subscribe► subscribe
Pfizer
PROCARDIA
nifedipine
CAPSULE;ORAL018482-001Approved Prior to Jan 1, 1982RXYes► subscribe► subscribe
Mylan
NIFEDIPINE
nifedipine
TABLET, EXTENDED RELEASE;ORAL201071-003Dec 3, 2010RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nifedipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms
ADALAT
nifedipine
CAPSULE;ORAL019478-002Sep 17, 19863,784,684► subscribe
Pfizer
PROCARDIA
nifedipine
CAPSULE;ORAL018482-001Approved Prior to Jan 1, 19823,644,627► subscribe
Bayer Pharms
ADALAT
nifedipine
CAPSULE;ORAL019478-001Nov 27, 19853,784,684► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc